Both in Pharmaceuticals
Lipocine vs Dare Bioscience
Over the past year LPCN returned −45.1% and DARE returned −66.5%; their daily moves had a correlation of 0.10.
LPCN −45.1% DARE −66.5%Growth of $1, one year, split-adjusted
| Metric | LPCN | DARE |
|---|---|---|
| Price | $1.51 | $0.6800 |
| Market cap | $12.4M | $13.4M |
| Today | +3.42% | +2.56% |
| 1 month | −30.1% | −16.6% |
| 6 months | −34.1% | −67.6% |
| Year to date | −81.2% | −64.8% |
| 1 year | −46.5% | −66.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | −70.6% |
| Net margin | — | −1590.4% |
| P/E (TTM) | — | — |
| Price / sales | 9.9× | 9.8× |
| Net cash | $23.3M | $12.5M |
| Dividend yield | — | — |
| Volatility (60d) | 56.7% | 99.5% |
| Short % of float | 4.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).